Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
Conditions: Primary Biliary Cholangitis; Primary Biliary Cirrhosis; Cholangitis; Cholestasis; Biliary Tract Diseases; Bile Duct Stricture Intervention: Drug: HTD1801 (BUDCA) Sponsor: HighTide Biopharma Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials